Ameritas Advisory Services LLC acquired a new stake in shares of Bunge Global SA (NYSE:BG – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 363 shares of the basic materials company’s stock, valued at approximately $29,000.
Other institutional investors also recently bought and sold shares of the company. Cromwell Holdings LLC grew its holdings in shares of Bunge Global by 4,175.0% during the second quarter. Cromwell Holdings LLC now owns 342 shares of the basic materials company’s stock valued at $27,000 after buying an additional 334 shares during the last quarter. Manchester Capital Management LLC boosted its stake in Bunge Global by 588.5% during the 1st quarter. Manchester Capital Management LLC now owns 420 shares of the basic materials company’s stock valued at $32,000 after purchasing an additional 359 shares during the last quarter. SVB Wealth LLC purchased a new stake in Bunge Global during the 1st quarter valued at $38,000. Caitong International Asset Management Co. Ltd boosted its stake in Bunge Global by 197.1% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 514 shares of the basic materials company’s stock valued at $39,000 after purchasing an additional 341 shares during the last quarter. Finally, Spire Wealth Management boosted its position in shares of Bunge Global by 66.5% during the first quarter. Spire Wealth Management now owns 556 shares of the basic materials company’s stock valued at $42,000 after buying an additional 222 shares during the last quarter. 86.23% of the stock is owned by hedge funds and other institutional investors.
Bunge Global Stock Performance
BG opened at $93.09 on Thursday. The company has a current ratio of 2.07, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. The company has a market cap of $18.62 billion, a price-to-earnings ratio of 9.30, a PEG ratio of 5.94 and a beta of 0.66. The company’s 50 day moving average is $82.54 and its 200 day moving average is $79.71. Bunge Global SA has a 12-month low of $67.40 and a 12-month high of $95.94.
Insiders Place Their Bets
In related news, Director Christopher Mahoney acquired 5,000 shares of the stock in a transaction dated Monday, August 18th. The shares were purchased at an average cost of $81.73 per share, with a total value of $408,650.00. Following the transaction, the director directly owned 7,164 shares in the company, valued at approximately $585,513.72. This represents a 231.05% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.80% of the company’s stock.
Analyst Ratings Changes
BG has been the topic of several recent analyst reports. Morgan Stanley increased their price objective on Bunge Global from $74.00 to $83.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 12th. JPMorgan Chase & Co. began coverage on shares of Bunge Global in a research note on Wednesday, August 20th. They issued an “overweight” rating and a $95.00 price target for the company. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Bunge Global in a report on Wednesday, October 8th. Three analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Bunge Global has an average rating of “Hold” and a consensus target price of $85.33.
Check Out Our Latest Report on BG
About Bunge Global
Bunge Global SA operates as an agribusiness and food company worldwide. It operates through four segments: Agribusiness, Refined and Specialty Oils, Milling, and Sugar and Bioenergy. The Agribusiness segment purchases, stores, transports, processes, and sells agricultural commodities and commodity products, including oilseeds primarily soybeans, rapeseed, canola, and sunflower seeds, as well as grains comprising wheat and corn; and processes oilseeds into vegetable oils and protein meals.
Further Reading
- Five stocks we like better than Bunge Global
- The 3 Best Fintech Stocks to Buy Now
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What is the Australian Securities Exchange (ASX)
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Bunge Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bunge Global and related companies with MarketBeat.com's FREE daily email newsletter.